SignatureFD’s Apyx Medical APYX Stock Holding History

SignatureFD’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-52,619	Closed	-$344K	–	3095
2022 Q1	$344K	Buy	+52,619	New	+$518K	0.01%	531
2018 Q4	–	Sell	-29,350	Closed	-$208K	–	1934
2018 Q3	$208K	Sell	29,350 -2,000	-6%	-$11.1K	0.02%	402
2018 Q2	$136K	Buy	+31,350	New	+$116K	0.02%	505

Other funds holding APYX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Invenire Partners Ridgefield, Connecticut $65.4M AUM 18.1% 1-Year Est. Return

SignatureFD's APYX Position: Q2 2022 in Review

SignatureFD sold out of Apyx Medical (APYX) in Q2 2022, closing a stake of 52,619 shares — an estimated $344K sold.

SignatureFD first reported a position in APYX in Q2 2018 and held it in 3 quarters. The position peaked at $344K in Q1 2022. 63 funds tracked by Wall St. Rank hold APYX as of Q2 2022.

SignatureFD reported no remaining Apyx Medical position as of Q2 2022 after selling out during the quarter.
SignatureFD sold 52,619 Apyx Medical shares in Q2 2022, an estimated $344K.
SignatureFD first reported a position in Apyx Medical in Q2 2018 and held it in 3 quarters.
SignatureFD's Apyx Medical position peaked at $344K in Q1 2022.
63 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2022.

Based on SignatureFD's 13F filing for Q2 2022, filed 10 Aug 2022.